These results indicated that HCC ascites specific proteins such as Enolase-1 responded and altered proteostasis in the unique cellular environment of HCC malignant ascetics and may predict HCC progression or be used as a potential therapeutic target for HCC. Here, ENO1 is linked to hepatocellular carcinoma.